Filter
111
Filtered Results: 111
Text search:
M.
Vitoriaa
Featured
Recommendations
14
New Publications
31
Language
Document type
No document type
72
Guidelines
21
Studies & Reports
15
Fact sheets
2
Manuals
1
Countries / Regions
Eastern Europe
5
Russia
4
Ukraine
2
Armenia
2
Global
2
Latin America and the Carribbean
2
Western and Central Europe
2
Brazil
2
North Macedonia
1
Thailand
1
Estonia
1
Mozambique
1
Africa
1
Eastern Europe and Central Asia
1
North America
1
Belgium
1
Belarus
1
South Africa
1
Georgia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
HIV & STI
16
TB
3
Communicable Diseases
2
Hepatitis
2
Guidelines
2
Maternal Health
2
Paediatrics
1
Buruli Ulcer
1
Humanitarian Aid
1
COVID-19
1
Public Health
1
Sexual Violence
1
Pediatrics
1
Countries
1
NCD
1
Cardiovascular Diseases
1
Child protection
1
Yellow Fever
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Studies & Reports
1
Humanitarian Crisis
1
Other
1
WASH
1
Gynaecology & Obstetrics
1
Neurology & Psychology
1
Water
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
Antiretroviral Treatment ART
12
HIV in Key Populations
12
TB/HIV Coinfection
11
Clinical Aspects, Treatment & Prevention
10
Transgender People
8
Treatment Guidelines HIV
6
ART Drug Resistance
5
General
5
Treatment & Prevention
4
Children & Adolescents
4
Drug resistance
4
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
4
HIV testing & services
3
Clinical Aspects
3
Opportunistic Infections
3
Access to treatment and laboratory
3
Co-Morbidities (except TB)
3
Reports & Studies
3
Policies & Strategies
2
General Reports
2
TB & Drug Abuse
2
Prevention & Control
2
Eastern Europe
2
Men who have sex with men (MSM)
2
TB/HIV
2
Drug resistant TB
2
Neurological Disorders
2
Substance Use Disorders & Addiction
2
Disease Prevention & Control
2
TB/HIV Global
2
Latin America & the Carribean
2
Clinical Guidelines
2
HIV service delivery
2
Drugs
1
Public Health
1
Childhood TB
1
Background PTSD in children
1
Vaccines & Immunization
1
Yellow Fever
1
Violence & Protection
1
Adults
1
HIV surveillance
1
Prevention Guidelines
1
Schizophrenia
1
HIV testing & disclosure
1
Hepatitis
1
HIV
1
General Studies & Reports
1
Others
1
Prophylaxis
1
Vaccination
1
Attention deficit hyperactivity disorder (ADHD)
1
Mental Health Guidelines
1
Reports
1
Russia
1
Sex Worker
1
Manuals
1
Key Resources
1
Laboratory
1
Studies
1
Infection Prevention & Hygiene
1
COVID-19
1
Country Specific
1
For Migrants & Refugees
1
Country specific documents
1
Prison & Detention
1
Child Protection
1
Paediatrics
1
Children & Mental Health
1
Oxygen Therapy
1
Gambling
1
Community Health Workers CHW
1
HIV &TB
1
Epilepsy
1
Mental Disorders
1
Prevention & Measures
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Taeniasis/Cysticercosis
1
Awareness
1
Armenia
1
General
1
Detection & Diagnosis
1
Policies and guidelines
1
Community Worker
1
Bipolar Affective Disorders
1
Prophylactic Treatment
1
Nutrition
1
Research & Access
1
HIV and coinfection
1
WASH
1
Epidemiology
1
Depression
1
Eastern and Southern Africa
1
Cyclones Idai & Kenneth
1
Supplement Article
WHO Guidelines for HIV PEP • CID 2015:60 (Suppl 3), S161 - S164
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Confronted with the important issue of patient safety, in 2002 the Fifty-fifth World Health Assembly adopted a resolution urging countries to pay the closest possible attention to the problem and to strengthen safety and monitoring systems. In May 2004, the Fifty-seventh World Health Assembly approv...
The main objective of this guidance is to provide scientific advice on public health principles and considerations for infection and prevention control of COVID-19 in migrant and refugee reception and detention centres in the European Union and European Economic Area (EU/EEA) and the United Kingdom ...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Taenia saginata is a zoonotic tapeworm that is of economic importance in countries where cattle are kept. The parasite is transmitted from human tapeworm carriers (taeniosis) to bovines (cysticercosis) by excretion of eggs or proglottids containing eggs into the environment via the stool. Bovines ca...
